- Home
- HUM vs IQV Comparison
HUM vs IQV Comparison
Compare HUM & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUM
- IQV
- Stock Information
- Founded
- HUM 1961
- IQV 1982
- Country
- HUM United States
- IQV United States
- Employees
- HUM N/A
- IQV N/A
- Industry
- HUM Medical Specialities
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- HUM Health Care
- IQV Health Care
- Exchange
- HUM Nasdaq
- IQV Nasdaq
- Market Cap
- HUM 28.2B
- IQV 25.6B
- IPO Year
- HUM 1993
- IQV 2013
- Fundamental
- Price
- HUM $244.28
- IQV $157.74
- Analyst Decision
- HUM Hold
- IQV Buy
- Analyst Count
- HUM 21
- IQV 20
- Target Price
- HUM $279.05
- IQV $226.80
- AVG Volume (30 Days)
- HUM 1.6M
- IQV 2.4M
- Earning Date
- HUM 07-30-2025
- IQV 07-21-2025
- Dividend Yield
- HUM 1.45%
- IQV N/A
- EPS Growth
- HUM N/A
- IQV 0.26
- EPS
- HUM 14.16
- IQV 7.35
- Revenue
- HUM $120,262,000,000.00
- IQV $15,497,000,000.00
- Revenue This Year
- HUM $8.71
- IQV $5.40
- Revenue Next Year
- HUM $2.77
- IQV $5.20
- P/E Ratio
- HUM $17.26
- IQV $21.44
- Revenue Growth
- HUM 10.09
- IQV 2.84
- 52 Week Low
- HUM $212.45
- IQV $134.65
- 52 Week High
- HUM $406.46
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- HUM 51.74
- IQV 59.08
- Support Level
- HUM $233.28
- IQV $153.01
- Resistance Level
- HUM $243.43
- IQV $159.85
- Average True Range (ATR)
- HUM 6.03
- IQV 4.04
- MACD
- HUM 1.38
- IQV 0.58
- Stochastic Oscillator
- HUM 65.05
- IQV 65.18
About HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.